Stocktoria
Fisher & Paykel Healthcare Corporation Limited FPH.NZ
Fisher & Paykel Healthcare Corporation Limited statistics & valuation
Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value (NZ$8.02); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
P / E vs its own history
Fisher & Paykel Healthcare Corporation Limited trades at about 53.9× earnings — below its 10-year norm (10-year range 46.1×–126×, median 64.4×).
Shaded band = 10-year range (46.1×–126×); dot = today's 53.9×.
Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.
Key ratios (by fiscal year)
| Ratio | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Gross margin | 63.7% | 41.4% | 60.3% | 59.5% |
| Operating margin | 20.7% | -29.0% | 14.5% | 15.2% |
| Net margin | 20.3% | 29.5% | 7.5% | 15.8% |
| Return on assets | 16.4% | 14.8% | 5.8% | 11.4% |
| Return on equity | 22.1% | 20.0% | 7.5% | 14.3% |
| Debt / equity | 0.02× | — | 0.02× | 0.05× |
| Current ratio | 2.31 | 1.87 | 1.83 | 2.67 |
Computed from company filings · NZ · as of 2026-03-31. Figures in NZD. Facts plus Stocktoria's own computed scores — not investment advice.